CRBX Stock Overview
A biotechnology company develops health testing and microbiome modulators to address a range of chronic and metabolic diseases. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Carbiotix AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 13.25 |
| 52 Week High | SEK 97.00 |
| 52 Week Low | SEK 3.58 |
| Beta | 0.85 |
| 1 Month Change | 37.73% |
| 3 Month Change | 76.67% |
| 1 Year Change | -73.45% |
| 3 Year Change | -99.00% |
| 5 Year Change | -97.72% |
| Change since IPO | -97.45% |
Recent News & Updates
Shareholder Returns
| CRBX | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | 50.2% | 2.0% | -2.0% |
| 1Y | -73.4% | -7.7% | 4.4% |
Return vs Industry: CRBX underperformed the Swedish Medical Equipment industry which returned -7.7% over the past year.
Return vs Market: CRBX underperformed the Swedish Market which returned 4.4% over the past year.
Price Volatility
| CRBX volatility | |
|---|---|
| CRBX Average Weekly Movement | 22.3% |
| Medical Equipment Industry Average Movement | 7.0% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in SE Market | 11.4% |
| 10% least volatile stocks in SE Market | 3.2% |
Stable Share Price: CRBX's share price has been volatile over the past 3 months compared to the Swedish market.
Volatility Over Time: CRBX's weekly volatility (22%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 5 | Erik Deaner | carbiotix.com |
Carbiotix AB (publ), a biotechnology company develops health testing and microbiome modulators to address a range of chronic and metabolic diseases. Its portfolio includes prebiotic ingredients and diagnostic testing services. The company develops CarbiAXOS, a second-generation prebiotic soluble fiber based on virgin and upcycled natural substrates containing arabinoxylo-oligosaccharides that is customized to meet customer needs to the production of short chain fatty acids or any other effect; and LinkGut, a health test.
Carbiotix AB (publ) Fundamentals Summary
| CRBX fundamental statistics | |
|---|---|
| Market cap | SEK 49.82m |
| Earnings (TTM) | -SEK 16.81m |
| Revenue (TTM) | SEK 3.25m |
15.3x
P/S Ratio-3.0x
P/E RatioIs CRBX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CRBX income statement (TTM) | |
|---|---|
| Revenue | SEK 3.25m |
| Cost of Revenue | SEK 1.40m |
| Gross Profit | SEK 1.85m |
| Other Expenses | SEK 18.66m |
| Earnings | -SEK 16.81m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -4.47 |
| Gross Margin | 57.00% |
| Net Profit Margin | -517.25% |
| Debt/Equity Ratio | 0% |
How did CRBX perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 21:35 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Carbiotix AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|